| The physiological role of alpha-synuclein and its relationship to Parkinson's Disease |
31 |
| The S100B story: from biomarker to active factor in neural injury |
30 |
| The energetic brain - A review from students to students |
28 |
| White matter degeneration in vascular and other ageing-related dementias |
25 |
| alpha-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities |
24 |
| Cerebral blood flow in normal aging adults: cardiovascular determinants, clinical implications, and aerobic fitness |
23 |
| How is alpha-synuclein cleared from the cell? |
23 |
| Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis |
22 |
| Manganese causes neurotoxic iron accumulation via translational repression of amyloid precursor protein and H-Ferritin |
21 |
| Genetic and epigenetic contribution to astrocytic gliomas pathogenesis |
21 |
| Redox proteomics and amyloid beta-peptide: insights into Alzheimer disease |
20 |
| The m6A-epitranscriptomic signature in neurobiology: from neurodevelopment to brain plasticity |
20 |
| Lysosome biogenesis in health and disease |
20 |
| Pathomechanisms of TDP-43 in neurodegeneration |
18 |
| Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration |
17 |
| Inflammatory mechanisms in neurodegeneration |
17 |
| High mobility group box 1 (HMGB1) as a novel frontier in epileptogenesis: from pathogenesis to therapeutic approaches |
16 |
| In vivo molecular imaging of neuroinflammation in Alzheimer's disease |
16 |
| The role of innate immunity in mucopolysaccharide diseases |
16 |
| Complex neuroprotective and neurotoxic effects of histone deacetylases |
15 |
| Sphingosine 1-phosphate receptors regulate TLR4-induced CXCL5 release from astrocytes and microglia |
15 |
| Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions |
15 |
| Diet-induced insulin resistance elevates hippocampal glutamate as well as VGLUT1 and GFAP expression in A beta PP/PS1 mice |
14 |
| Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy |
14 |
| The GABAergic system as a therapeutic target for Alzheimer's disease |
14 |
| Identification and quantification of blood-brain barrier transporters in isolated rat brain microvessels |
14 |
| Alterations in synaptic function and plasticity in Huntington disease |
14 |
| Microglia and the aging brain: are senescent microglia the key to neurodegeneration? |
14 |
| Ribosomal biogenesis as an emerging target of neurodevelopmental pathologies |
14 |
| Hexokinase 2-dependent hyperglycolysis driving microglial activation contributes to ischemic brain injury |
14 |
| High-affinity heterotetramer formation between the large myelin-associated glycoprotein and the dynein light chain DYNLL1 |
13 |
| GABA(A) receptor subunit expression changes in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus |
13 |
| Cellular models of alpha-synuclein toxicity and aggregation |
13 |
| Parkinson's disease biomarkers based on alpha-synuclein |
12 |
| The role of adenosine receptors in mood and anxiety disorders |
12 |
| Stress-induced tRNA cleavage and tiRNA generation in rat neuronal PC12 cells |
12 |
| Cortical progenitor biology: key features mediating proliferation versus differentiation |
12 |
| Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis |
12 |
| Role of the endolysosomal system in Parkinson's disease |
12 |
| Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice |
12 |
| Cerebral amyloid angiopathy as a cause of neurodegeneration |
12 |
| Astrocyte truncated tropomyosin receptor kinase B mediates brain-derived neurotrophic factor anti-apoptotic effect leading to neuroprotection |
11 |
| Iron promotes alpha-synuclein aggregation and transmission by inhibiting TFEB-mediated autophagosome-lysosome fusion |
11 |
| Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration |
11 |
| Adult neurogenesis and its role in brain injury and psychiatric diseases |
11 |
| alpha-synuclein oligomers enhance astrocyte-induced synapse formation through TGF-beta 1 signaling in a Parkinson's disease model |
10 |
| Nuclear factor-kappa beta as a therapeutic target for Alzheimer's disease |
10 |
| Current status and potential role of circular RNAs in neurological disorders |
10 |
| Antibodies against alpha-synuclein: tools and therapies |
10 |
| Differential toxicity of TAR DNA-binding protein 43 isoforms depends on their submitochondrial localization in neuronal cells |
10 |
